Potential Targets for Antifungal Drug Discovery Based on Growth and Virulence in Candida albicans
Author(s) -
Xiuyun Li,
Yinglong Hou,
Long-Tao Yue,
Shuyuan Liu,
Juan Du,
Shujuan Sun
Publication year - 2015
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00726-15
Subject(s) - candida albicans , virulence , antifungal drug , antifungal drugs , corpus albicans , antifungal , biology , microbiology and biotechnology , drug , pharmacology , genetics , gene
Fungal infections, especially infections caused byCandida albicans , remain a challenging problem in clinical settings. Despite the development of more-effective antifungal drugs, their application is limited for various reasons. Thus, alternative treatments with drugs aimed at novel targets inC. albicans are needed. Knowledge of growth and virulence in fungal cells is essential not only to understand their pathogenic mechanisms but also to identify potential antifungal targets. This article reviews the current knowledge of the mechanisms of growth and virulence inC. albicans and examines potential targets for the development of new antifungal drugs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom